What is Microtrace?
Microtrace operates as a premier materials analysis laboratory, distinguished by its ability to characterize and identify minute quantities of unknown substances. Utilizing advanced microscopy and sophisticated microchemical methodologies, the firm provides essential analytical support across a diverse spectrum of sectors, including pharmaceuticals, food safety, environmental monitoring, and manufacturing. With a legacy spanning over three decades, the company has established itself as an international authority in forensic science, offering specialized services that range from contaminant identification to complex forensic art analysis. Their commitment to scientific rigor makes them a preferred partner for organizations requiring precise, defensible data for litigation and quality control.
How much funding has Microtrace raised?
Microtrace has raised a total of $348K across 2 funding rounds:
Debt
$150K
Debt
$198K
Debt (2020): $150K with participation from PPP
Debt (2021): $198K led by PPP
Key Investors in Microtrace
PPP
Public-Private Partnership
What's next for Microtrace?
With the recent capital deployment, Microtrace is poised to scale its laboratory infrastructure and further refine its diagnostic capabilities. The strategic focus will likely center on integrating next-generation microscopy technologies to address the evolving needs of the pharmaceutical and environmental sectors. By strengthening its technical foundation, the firm aims to broaden its service portfolio, ensuring that it remains at the forefront of particle identification and forensic research. This growth phase is expected to solidify Microtrace's position as an indispensable resource for industries facing increasingly stringent regulatory and safety standards, ultimately driving long-term value for its stakeholders.
See full Microtrace company page
